Background
==========

Chronic kidney disease (CKD), the prevalence of which is estimated to be 8--16% worldwide, is an independent risk factor for morbidity and mortality in patients with cardiovascular disease \[[@b1-medscimonit-20-1389]\]. Sodium is important in maintaining irritability and conduction of nerve and muscle tissues and assists in the regulation of acid-base balance. Hyponatremia is the most common electrolyte disorder encountered in patients in the neurological and neurosurgical Intensive Care Units and can worsen existing neurological deficits \[[@b2-medscimonit-20-1389]--[@b4-medscimonit-20-1389]\]. Neurological disorders that cause hyponatremia are diverse and include neurotrauma, subarachnoid hemorrhage, intracerebral hemorrhage, meningitis, and stroke \[[@b4-medscimonit-20-1389]--[@b6-medscimonit-20-1389]\]. One reason for the increased risk of cardiovascular disease in patients with chronic kidney disease is accelerated atherosclerosis. Advanced asymptomatic atherosclerosis in the carotid arteries is observed in patients during the early stages of CKD, with intima and media thickness increasing directly with a decline in glomerular filtration rate \[[@b7-medscimonit-20-1389]\]. Concentric arterial calcification is associated with arterial stiffness, resulting in a high pulse pressure and increased characteristic aortic impedance. It has been observed that there is an association between intima calcification and increased incidence of ischemic stroke \[[@b8-medscimonit-20-1389]\].

The aim of this study was to evaluate the influence of chronic kidney disease and sodium disturbances on the clinical course of acute and sub-acute stage of first-ever ischemic stroke.

Material and Methods
====================

This prospective, non-randomized study, performed from January 2013 to July 2013, consisted of 464 patients aged 70.42±11.49 years (250 women) with previously diagnosed chronic kidney disease (according to KDIGO 2012 guidelines) \[[@b9-medscimonit-20-1389]\] admitted to the Department of Neurology due to a first-ever ischemic stroke commensurate with the WHO criteria \[[@b10-medscimonit-20-1389]\]. The study group consisted of patients in which computed tomography (CT) of the head, performed during the first 24 h of an ischemic event, did not reveal any abnormalities or only revealed early ischemic changes. Patients with both symptoms of transient ischemic attack (TIA) and intracranial hemorrhage, complicated by ischemic stroke due to vasospasm, were excluded from the study. Ethics committee approval was not required because the study was based on a routine laboratory tests performed in every patient with a stroke -- no patient identification was recorded and thus the study did not fulfill the criterion of a medical experiment.

The patients were divided into 1 of 2 subgroups:

a.  depending on the value eGFR: ≤60 ml/(min×1.73 m^2^) and \>60 ml/(min×1.73 m^2^).

b.  depending on the sodium concentration: ≤135mmol/l and \>135mmol/l.

The following parameters were analyzed:

1.  -- age at which first-ever ischemic stroke occurred;

2.  -- prevalence of comorbidities, such as hypertension, persistent atrial fibrillation, diabetes mellitus (DM), and dyslipidemia. Diagnosis of hypertension was consistent with the recommendation of the Polish Society of Cardiology \[[@b11-medscimonit-20-1389]\]; DM was diagnosed according to the criteria of the Polish Diabetes Association (2013) \[[@b12-medscimonit-20-1389]\]; dyslipidemia was defined as total cholesterol serum level \>200 mg/dl (\>5.18 mmol/L); or LDL-cholesterol serum level \>100 mg/dl (2.59 mmol/L), or HDL cholesterol serum level \<35 mg/dl (0.91 mmol/L), or triglyceride serum level \>135 mg/dL (1.53 mmol/L);

3.  -- neurological condition during the first 24 h of the ischemic event using the NIHSS score (National Institutes of Health Stroke Scale) \[[@b13-medscimonit-20-1389]\] (the neurological state was assessed as good or moderate: 0--12 points in NIHSS and severe \>12 points in NIHSS respectively);

4.  -- mortality rate at 1 month after their first-ever stroke;

5.  -- the status of functioning at 1 month after first-ever stroke measured by modified Rankin scale (mRS) \[[@b14-medscimonit-20-1389]\] during control medical examination in hospital (the functioning state after stroke was assessed as good when the patient did not require caregiver assistance (0--3 points in mRS) or severe when the patient was dependent on the caregiver or died (4--6 points in mRS).

The acute phase of stroke was defined as a period of 1--7 days. The subacute period was defined as 1--3 weeks.

All parameters were also analyzed after the respondents were divided by sex.

Laboratory tests
----------------

Laboratory tests were conducted in the Central Laboratory of the Upper Silesian Medical Centre in Katowice. Venous blood samples (20 ml), taken on admission, were withdrawn into plastic test tubes (Vacutainer system). The tubes were allowed to clot, and then centrifuged at room temperature (1000 × G) for 10 min.

The spectrophotometric method (Point Scientific Inc., Michigan, USA) was used to determine the serum level of sodium (Na), glucose, creatinine, and lipids. Estimated glomerular filtration rate (eGFR) was calculated according to the Chronic Kidney Disease Epidemiology Collaboration \[[@b14-medscimonit-20-1389]\].

Statistical analysis
--------------------

All parametric values were expressed as mean with standard deviations (SD). All statistical analyses were performed using the STATISTICA 8.0 PL software. The distribution was analyzed using the Kolmogorov-Smirnoff test. Because of the size of the control group, the subgroups, and the nonparametric distribution of some of the parameters, the Mann-Whitney U test was used to compare the study groups and for age we used the *t* test. For categorical variables, we used chi-square tests. P\<0.05 was considered statistically significant.

Results
=======

The age of patients with their first-ever stroke and the prevalence of selected comorbidities (hypertension, atrial fibrillation, dyslipidemia and diabetes mellitus) did not differ in subgroups of patients with decreased eGFR (≤60 *vs*. \>60 mL/(min×1.73 m^2^) ([Table 1](#t1-medscimonit-20-1389){ref-type="table"}).

Neurological condition in the acute stage of a first-ever stroke, evaluated using the NIHSS score, was worse, and the average score in mRS (indicative of a greater degree of disability within 30 days after stroke) was higher in patients with eGFR ≤60 ml/(min×1.73 m^2^) ([Table 2](#t2-medscimonit-20-1389){ref-type="table"}). The mortality rate within 1 month did not differ in patients when divided according to eGFR (7% *vs.* 5%; p=0.4). Men with eGFR ≤60 ml/(min×1.73 m^2^) were characterized by greater neurological deficits on the first day of stroke and increased mortality within 1 month after neurological event compared to women. In patients with eGFR \>60 ml/(min×1.73 m^2^), male sex was more often associated with worse outcome at 1 month after stroke ([Table 3](#t3-medscimonit-20-1389){ref-type="table"}).

The mean serum sodium concentration ranged from 127 to 152 mmol/l. Hyponatremia was associated with a more severe condition of the patients in both the acute and sub-acute stages of stroke and higher incidence of death within 1 month (13.6% *vs.* 4%; Na ≤135 mmol/l *vs.* Na ≥135 mmol/l, respectively) ([Table 4](#t4-medscimonit-20-1389){ref-type="table"}). Men with hyponatremia were characterized by greater neurological deficits on the first day of stroke and increased mortality within 1 month after. A greater level of disability was observed in men with a normal serum sodium level ([Table 5](#t5-medscimonit-20-1389){ref-type="table"}).

Discussion
==========

CKD is a major risk factor for cardiovascular disease, including stroke \[[@b15-medscimonit-20-1389]--[@b17-medscimonit-20-1389]\]. Available data indicate an increased risk of cerebral infarction and intracerebral hemorrhage in patients with CKD (40--46% and 39%, respectively) \[[@b18-medscimonit-20-1389]--[@b20-medscimonit-20-1389]\]. The factors that increase the incidence of stroke in the course of kidney disease include accelerated atherosclerosis, calcification of the cerebral arteries, hemodynamic disturbances, anemia, and anticoagulation therapy \[[@b17-medscimonit-20-1389],[@b20-medscimonit-20-1389]\]. Patients with impaired renal function often develop lobar hemorrhages with extensive damage to brain structures, characterized by a more severe clinical course \[[@b21-medscimonit-20-1389]\]. Chronic kidney failure worsens the early (the course of the acute stage of stroke), as well as the late prognosis (in terms of mobility and survival), and increases the risk of recurrent stroke \[[@b22-medscimonit-20-1389]--[@b26-medscimonit-20-1389]\]. CKD was 1 of the 9 most important risk factors for recurrent stroke within 1 year of diagnosis of the previous incident, according to the Fukuoka Stroke Registry Study (FSR) \[[@b27-medscimonit-20-1389]\]. We found that in the acute stage of stroke, patients with a decreased glomerular filtration rate (eGFR \<60 ml/min) have a greater degree of neurological damage. These patients often remain dependent on help for daily activities within 1 month after the stroke. The results obtained allow us to conclude that hyponatremia influences the course of the acute and sub-acute stroke periods. The mean age of onset of stroke and the incidence of other diseases likely affect its course, and did not differ significantly for the 2 subgroups. We did not observe that a reduced glomerular filtration rate increased the mortality during the month of follow-up. However, it must be noted that male sex had a negative impact on neurological condition in the acute stage of stroke and survival rate within 1 month of the onset of cerebral ischemia. The age and sex differences in the incidence and course of stroke in men and women have already been demonstrated, but the reason for that phenomenon remains unclear. The impact of sex on the incidence, course, and outcome of stroke is analyzed with respect to the hormonal profile. Risk factor profiles are different, with men having a higher incidence of coronary artery disease, dyslipidemia, diabetes, carotid stenosis, and tobacco smoking, while women had a higher incidence of atrial fibrillation and hypertension. When compared to men, women were older and more significantly impacted by acute stroke. Some authors demonstrated significantly worse functional outcomes for women compared to men at 1 and 5 years after stroke \[[@b28-medscimonit-20-1389]--[@b31-medscimonit-20-1389]\]. Other authors have observed that hemorrhagic transformation in acute ischemic stroke and increased mortality during hospitalization were more common in patients with CKD \[[@b32-medscimonit-20-1389]\]. Hirano et al. demonstrated that patients with renal impairment receive less benefit from thrombolytic therapy in the acute stage of stroke \[[@b33-medscimonit-20-1389]\]. In addition, the same authors demonstrated a higher incidence of iatrogenic bleeding into intracranial structures, causing a high degree of post-stroke morbidity and increased mortality in this group of patients. It has also been demonstrated that chronic kidney disease has a negative effect on the course of other cardiovascular diseases, including coronary heart disease, and a worse prognosis after angioplasty \[[@b34-medscimonit-20-1389]--[@b42-medscimonit-20-1389]\]. Patients with chronic kidney disease have a higher incidence of occult stroke and microhemorrhages, regardless of incidents of acute cerebral ischemia \[[@b16-medscimonit-20-1389],[@b17-medscimonit-20-1389]\]. Imaging studies in patients on hemodialysis (conducted both pre and post mortem) demonstrate the presence of small-vessel infarcts and cerebral atrophy \[[@b16-medscimonit-20-1389],[@b41-medscimonit-20-1389]\]. Hyponatremia is another factor that may affect the course and prognosis of patients after stroke. It is the most common electrolyte disorder in hospitalized patients in various clinical settings \[[@b42-medscimonit-20-1389]\]. Even a small reduction in the serum sodium level is associated with a worse prognosis, regardless of the disease. These observations have also been made in patients with myocardial infarction, pulmonary hypertension, and subarachnoid hemorrhage \[[@b43-medscimonit-20-1389],[@b44-medscimonit-20-1389]\]. Additionally, Wannamethee et al. recognized hyponatremia as a potential risk factor for stroke \[[@b45-medscimonit-20-1389]\]. The relationship between hyponatremia and clinical outcomes after stroke is not completely understood. The worse outcomes in patients with hyponatremia may possibly be explained by osmotic changes (decreased plasma osmolality) resulting in cerebral edema and secondarily increased intracranial pressure. Osmotic changes within neurocytes could also be responsible for cellular damage and their premature death. In the present study, hyponatremia was associated with a more severe condition of the patients in the acute and subacute phases of their first-ever stroke and a higher incidence of mortality within 1 month of the onset of their first-ever stroke. Therefore, hyponatremia observed in patients with their first-ever stroke could be regarded as an essential risk factor for increased mortality and worse prognosis. Interestingly, in the present study, the effect of hyponatremia on both neurologic condition during the first 24 h after stroke and increased mortality rate was significantly higher in men. Other authors obtained similar results. Rodriguez et al. found hyponatremia to be an independent predictor of long-term cumulative mortality rates at 3 and 12 months after stroke and a worse condition at discharge from hospital. It is important to note that no difference has been found when comparing stroke etiologies (ischemic *vs.* hemorrhagic) in patients with hyponatremia \[[@b46-medscimonit-20-1389]\]. Huang et al. demonstrated that decreased sodium level (\<135 mmol/l) was a predictor of 3-year mortality in patients with their first-ever acute stroke, independent of other clinical predictors of adverse outcome \[[@b47-medscimonit-20-1389]\]. This study is one of the few that evaluated the effect of kidney function and sodium disturbances on the course and clinical outcomes in patients after their first-ever stroke during short-term observation. It is not known whether adequate correction of sodium level in patients with acute stroke will improve prognosis and reduce the risk of death. It would be interesting to discover why men with impaired renal function had a more unfavorable course of stroke and higher post-stroke mortality. These findings require further investigation.

Conclusions
===========

Renal impairment and hyponatremia are associated with worse neurological condition in patients in the acute stage of their first-ever stroke and worse outcomes within 1 month after a neurological event. Male patients with impaired kidney function and hyponatremia have a more severe course of a first-ever stroke and greater short-term mortality compared to females.

**Source of support:** Departmental sources

###### 

Patients' clinical characteristics (n,%).

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Parameter               Patients with eGFR ≤60 ml/(min×1.73 m^2^)\   Patients with eGFR \>60 ml/(min×1.73 m^2^)\   *p* (test Chi^2^)
                          n=155                                        n=309                                         
  ----------------------- -------------------------------------------- --------------------------------------------- ----------------------------------------------------------
  Age                     71.1±11.49                                   69.75±11.5                                    0.66[\*](#tfn1-medscimonit-20-1389){ref-type="table-fn"}

  Arterial hypertension   65 (41.9%)                                   136 (44.0%)                                   0.67

  Atrial fibrillation     42 (27.1%)                                   105 (35.0%)                                   0.13

  Lipid disorders         50 (32.3%)                                   82 (26.5%)                                    0.19

  Diabetes                64 (41.3%)                                   120 (38.8%)                                   0.61
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

t-student's test; eGFR -- estimated glomerular filtration rate.

###### 

Clinical state and mortality according to eGFR (mean ±SD).

  -------------------------------------------------------------------------------------------------
  Parameter   eGFR ≤60 ml/(min×1.73 m^2^)\   eGFR \>60 ml/(min×1.73 m^2^)\   *p* (U Mann-Whitney)
              n=155                          n=309                           
  ----------- ------------------------------ ------------------------------- ----------------------
  NIHSS       6.85±6.55                      5.74±6.12                       0.0199

  mRankin     3.10±1.91                      2.43±2.01                       0.0005
  -------------------------------------------------------------------------------------------------

eGFR -- estimated glomerular filtration rate; NIHSS -- National Institutes of Health Stroke Scale on the 1^st^ day of stroke; mRankin -- modified Rankin scale on the 30^th^ day after stroke.

###### 

Clinical state and mortality in female and male according to eGFR (n,%).

                      eGFR ≤60 ml/min (n,%)   eGFR \>60 ml/min (n,%)                                            
  ------------------- ----------------------- ------------------------ ------------ ------------- ------------- --------
  NIHSS 0--12         57 (89.1%)              65 (71.4%)               0.0083       127 (84.7%)   131 (82.4%)   0.5900
  NIHSS \>12          7 (10.9%)               26 (28.6%)               23 (15.3%)   28 (17.6%)                  
  mRankin 0--3        35 (54.7%)              39 (42.9%)               0.1466       106 (70.7%)   92 (57.9%)    0.0190
  mRankin 4--6        29 (45.3%)              52 (57.1%)               44 (29.3%)   67 (42.1%)                  
  1 month mortality   1 (1.6%)                10 (11.0%)               0.0244       5 (3.3%)      11 (6.9%)     0.1552

eGFR -- estimated glomerular filtration rate; NIHSS -- National Institutes of Health Stroke Scale.

###### 

Clinical state, mortality according to serum sodium concentration (mean ±SD).

  -----------------------------------------------------------------------
  Parameter   Na ≤135 mmol/l\   Na \>135 mmol/l\   *p* (U Mann-Whitney)
              n=88              n=376              
  ----------- ----------------- ------------------ ----------------------
  NIHSS       8.22±6.58         5.62±6.11          0.0001

  mRankin     3.83±1.78         2.38±1.96          0.0000
  -----------------------------------------------------------------------

NIHSS -- National Instytutes of Health Stroke Scale; mRankin -- modified Rankin scale.

###### 

Clinical state, mortality in female i male according to serum sodium concentration.

                      Na ≤135 mmol/l (n,%)   Na \>135 mmol/l (n,%)                                            
  ------------------- ---------------------- ----------------------- ------------ ------------- ------------- --------
  NIHSS 0--12         32 (82.1%)             30 (61.2%)              0.0334       152 (86.9%)   166 (82.6%)   0.2529
  NIHSS \>12          7 (17.9%)              19 (38.8%)              23 (13.1%)   35 (17.4%)                  
  mRankin 0--3        15 (38.5%)             16 (32.7%)              0.5710       126 (72%)     115 (57.2%)   0.0029
  mRankin 4--6        24 (61.5%)             33 (67.3%)              49 (28%)     86 (42.8%)                  
  1 month mortality   2 (5.1%)               10 (20.4%)              0.0380       4 (2.3%)      11 (5.5%)     0.1153

NIHSS -- National Institutes of Health Stroke Scale; mRankin -- modified Rankin scale.
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